ChemoCentryx Historical PE Ratio image   This CCXI PE ratio history page last updated 11/8/2022
ChemoCentryx Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/9/2022
50.79-0.44-1.76NA
Q1 2022
5/5/2022
15.64-0.55-2.20NA
Q4 2021
3/1/2022
29.46-0.58-2.32NA
Q3 2021
11/9/2021
38.02-0.32-1.28NA
Q2 2021
8/9/2021
14.60-0.56-2.24NA
Q1 2021
4/29/2021
45.00-0.43-1.72NA
Q4 2020
3/1/2021
68.40-0.43-1.72NA
Q3 2020
11/9/2020
57.98-0.35-1.40NA
Q2 2020
8/10/2020
55.720.291.1648.0
Q1 2020
5/11/2020
55.94-0.35-1.40NA
Q4 2019
3/10/2020
45.78-0.26-1.04NA
Q3 2019
11/4/2019
9.36-0.22-0.88NA
Q2 2019
8/5/2019
7.62-0.26-1.04NA
Q1 2019
5/6/2019
13.41-0.23-0.92NA
Q4 2018
3/11/2019
10.33-0.21-0.84NA
Q3 2018
11/8/2018
11.70-0.22-0.88NA
Q2 2018
8/9/2018
11.60-0.14-0.56NA
Q1 2018
5/9/2018
11.21-0.19-0.76NA
Q4 2017
3/9/2018
12.190.803.203.8
Q3 2017
11/7/2017
7.09-0.13-0.52NA
Q2 2017
8/8/2017
10.14-0.19-0.76NA
Q1 2017
5/10/2017
7.08-0.12-0.48NA
Q4 2016
3/14/2017
6.69-0.16-0.64NA
Q3 2016
11/7/2016
6.72-0.15-0.60NA
Q2 2016
8/8/2016
4.37-0.22-0.88NA
Q1 2016
5/10/2016
2.99-0.34-1.36NA
Q4 2015
3/14/2016
3.48-0.26-1.04NA
Q3 2015
11/9/2015
6.67-0.26-1.04NA
Q2 2015
8/6/2015
7.54-0.28-1.12NA
Q1 2015
5/6/2015
6.68-0.28-1.12NA
Q4 2014
3/12/2015
8.06-0.28-1.12NA
Q3 2014
11/5/2014
5.53-0.25-1.00NA
Q2 2014
8/5/2014
5.51-0.28-1.12NA
Q1 2014
5/8/2014
5.39-0.27-1.08NA
Q4 2013
3/13/2014
6.91-0.23-0.92NA
Q3 2013
11/7/2013
4.67-0.22-0.88NA
Q2 2013
8/12/2013
12.66-0.23-0.92NA
Q1 2013
5/13/2013
13.26-0.28-1.12NA
Q4 2012
3/13/2013
14.00-0.28-1.12NA
ChemoCentryx PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/9/2022
50.79-0.44-1.89NA
Q1 2022
5/5/2022
15.64-0.55-2.01NA
Q4 2021
3/1/2022
29.46-0.58-1.89NA
Q3 2021
11/9/2021
38.02-0.32-1.74NA
Q2 2021
8/9/2021
14.60-0.56-1.77NA
Q1 2021
4/29/2021
45.00-0.43-0.92NA
Q4 2020
3/1/2021
68.40-0.43-0.84NA
Q3 2020
11/9/2020
57.98-0.35-0.67NA
Q2 2020
8/10/2020
55.720.29-0.54NA
Q1 2020
5/11/2020
55.94-0.35-1.09NA
Q4 2019
3/10/2020
45.78-0.26-0.97NA
Q3 2019
11/4/2019
9.36-0.22-0.92NA
Q2 2019
8/5/2019
7.62-0.26-0.92NA
Q1 2019
5/6/2019
13.41-0.23-0.80NA
Q4 2018
3/11/2019
10.33-0.21-0.76NA
Q3 2018
11/8/2018
11.70-0.220.2546.8
Q2 2018
8/9/2018
11.60-0.140.3434.1
Q1 2018
5/9/2018
11.21-0.190.2938.7
Q4 2017
3/9/2018
12.190.800.3633.9
Q3 2017
11/7/2017
7.09-0.13-0.60NA
Q2 2017
8/8/2017
10.14-0.19-0.62NA
Q1 2017
5/10/2017
7.08-0.12-0.65NA
Q4 2016
3/14/2017
6.69-0.16-0.87NA
Q3 2016
11/7/2016
6.72-0.15-0.97NA
Q2 2016
8/8/2016
4.37-0.22-1.08NA
Q1 2016
5/10/2016
2.99-0.34-1.14NA
Q4 2015
3/14/2016
3.48-0.26-1.08NA
Q3 2015
11/9/2015
6.67-0.26-1.10NA
Q2 2015
8/6/2015
7.54-0.28-1.09NA
Q1 2015
5/6/2015
6.68-0.28-1.09NA
Q4 2014
3/12/2015
8.06-0.28-1.08NA
Q3 2014
11/5/2014
5.53-0.25-1.03NA
Q2 2014
8/5/2014
5.51-0.28-1.00NA
Q1 2014
5/8/2014
5.39-0.27-0.95NA
Q4 2013
3/13/2014
6.91-0.23-0.96NA
Q3 2013
11/7/2013
4.67-0.22-1.01NA
Q2 2013
8/12/2013
12.66-0.23NANA
Q1 2013
5/13/2013
13.26-0.28NANA
Q4 2012
3/13/2013
14.00-0.28NANA
Quotes delayed 20 minutes

Email EnvelopeFree CCXI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ChemoCentryx (CCXI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CDAK PE Ratio History
CDMO PE Ratio History
CDNA PE Ratio History
CDRE PE Ratio History
CDTX PE Ratio History
CDXC PE Ratio History
CELC PE Ratio History
CEMI PE Ratio History
CERC PE Ratio History
CERE PE Ratio History
How should the CCXI historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like ChemoCentryx. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CCXI Historical PE Ratio page.

What is the average historical PE for CCXI based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CCXI historical PE ratio using the annualized quarterly earnings method works out to 25.9.

What is the average historical PE for CCXI based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CCXI historical PE ratio using the TTM earnings method works out to 38.4.

On this page we presented the ChemoCentryx Historical PE Ratio information for ChemoCentryx' stock. The average CCXI historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 25.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CCXI historical PE based on this TTM earnings result method is 38.4. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CCXI historical PE result, against the recent PE: when this page was posted on 10/20/2022, the most recent closing price for CCXI had been 51.99, and the most recent quarterly earnings result, annualized, was 1.16. Meanwhile, the most recent TTM earnings summed to 0.25. From these numbers, we calculate the recent CCXI PE on 10/20/2022 based on annualized quarterly EPS was 44.8. Based on CCXI's history, that recent PE is elevated relative to the historical average, with the recent PE 73.0% higher than the historical average PE across our data set for ChemoCentryx. Looking at the recent CCXI PE on 10/20/2022 based on TTM EPS, we calculate the ratio at 208.0. Based on CCXI's history, that recent PE is elevated relative to the historical average, with the recent PE 441.7% higher than the historical average PE across our ChemoCentryx data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on CCXI or any other given stock, valuation analysis for CCXI can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate ChemoCentryx PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CCXI. Thanks for visiting, and the next time you need to research CCXI Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: RUBI Price Target, Top Ten Hedge Funds Holding CAMH, Top Ten Hedge Funds Holding MXIM.

 

ChemoCentryx Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.